The microbial characterization by a restricted spectrum of tests pre-selected and appropriate to various types of research studies is termed as microbial identification. Microbial identification is applied for accurate identification of environmental isolates to actively support the environmental monitoring programs. These programs are carried out in pharmaceutical manufacturing environment as a part of cGMP, and to reduce risk of contamination and are implemented with Corrective and Preventive Actions (CAPAs). The microbial identification of bacteria and fungi as per species is recommended under guidelines of the U.S., European and Japanese Pharmacopeia. The two types of microbial identification techniques are genotype and phenotype. Genotype includes collection of organism’s detailed hereditary information and phenotype covers information of organism related with its morphology, chemical behavior and other physical properties. The phenotypic methods consist immunological methods, fatty acid profiles, fourier transform infrared (FITP) spectroscopy, mass spectroscopy and biochemical essay. The genotypic method consists of applications such as nucleic acid amplification techniques and genetic fingerprinting. The microbial identification market can be segmented on the basis of products such as PCR, high-power microscopes, mass spectrometers, automated microbial detection systems, polystainers, flow cytometers, microarrays, and other instruments. The accessories that are used in this product market are plates, media, reagents, kits and other accessories. The application market of microbial identification technique can be segmented as human and animal diagnosis, environmental applications, pharmaceutical applications and food and beverage testing. The end users present in this market comprises government/private institutes and diagnostic laboratories, hospitals, blood banks, food and beverage manufacturers, pharmaceutical companies, environmental study agencies, NGOs, research laboratories, pharmaceutical companies, independent research laboratories and culture collection repositories.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=235031
Some of the major factors driving the growth of microbial identification include rising prevalence of infectious diseases, technological developments and upgradation in products, rising food safety concerns are also accompanied by other government initiatives. The government initiatives taken with respect to microbial identification are focus on antimicrobial identification, bioterrorism surveillance, and emerging geographies. However, stringent regulatory framework and high costs of these instruments may limit the future growth of microbial identification market.
According to market experts, the application of microbial identification technique in regions such as Western Europe and North America was high due to presence of modern technology, presence of leading pharmaceutical and biotechnology companies. Regions with rare cases included Asia-Pacific and other geographic regions as some of the organizations and universities do not follow standard guidelines and accompanied by modern diagnostic technologies. North America was observed to be the largest market due to increasing awareness related with infectious diseases and high R&D investments in prevention technologies. Due to presence of leading R&D laboratories and presence of major pharmaceutical and biotechnology companies Europe was observed to be the second largest microbial identification market. Asia-Pacific and Rest of the World are the most potential markets for microbial identification. This growth was observed due to the presence of emerging economies and growing healthcare and food industry. Increasing government initiatives against standard cGMP and maintenance of manufacturing environment regulation are expected to boost the market in emerging economies such as China, India, and Brazil.
Some of the key players in microbial identification market are Qiagen N.V., Becton, Dickinson and Company, Charles River Laboratories Inc., Siemens Healthcare, Biomérieux SA, Thermo Fisher Scientific, Inc., Bruker Corporation Biolog Inc., Shimadzu Corporation, Sigma-Aldrich Corporation, and others.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
– Market growth drivers
– Factors limiting market growth
– Current market trends
– Market structure
– Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
– This report provides pin-point analysis for changing competitive dynamics
– It provides a forward looking perspective on different factors driving or restraining market growth
– It provides a six-year forecast assessed on the basis of how the market is predicted to grow
– It helps in understanding the key product segments and their future
– It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
– It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
– It provides distinctive graphics and exemplified SWOT analysis of major market segments
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=235031